BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27687599)

  • 1. [Pulmonary arterial hypertension, bone marrow, endothelial cell precursors and serotonin].
    Ayme-Dietrich E; Banas SM; Monassier L; Maroteaux L
    Biol Aujourdhui; 2016; 210(2):79-88. PubMed ID: 27687599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertension.
    Launay JM; Hervé P; Callebert J; Mallat Z; Collet C; Doly S; Belmer A; Diaz SL; Hatia S; Côté F; Humbert M; Maroteaux L
    Blood; 2012 Feb; 119(7):1772-80. PubMed ID: 22186990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.
    Long L; MacLean MR; Jeffery TK; Morecroft I; Yang X; Rudarakanchana N; Southwood M; James V; Trembath RC; Morrell NW
    Circ Res; 2006 Mar; 98(6):818-27. PubMed ID: 16497988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
    Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
    Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension.
    Toshner M; Voswinckel R; Southwood M; Al-Lamki R; Howard LS; Marchesan D; Yang J; Suntharalingam J; Soon E; Exley A; Stewart S; Hecker M; Zhu Z; Gehling U; Seeger W; Pepke-Zaba J; Morrell NW
    Am J Respir Crit Care Med; 2009 Oct; 180(8):780-7. PubMed ID: 19628780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of circulating vascular progenitors in angiogenesis, vascular healing, and pulmonary hypertension: lessons from animal models.
    Sata M
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1008-14. PubMed ID: 16456096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Marrow-Derived Proangiogenic Cells Mediate Pulmonary Arteriole Stiffening via Serotonin 2B Receptor Dependent Mechanism.
    Bloodworth NC; Clark CR; West JD; Snider JC; Gaskill C; Shay S; Scott C; Bastarache J; Gladson S; Moore C; D'Amico R; Brittain EL; Tanjore H; Blackwell TS; Majka SM; Merryman WD
    Circ Res; 2018 Dec; 123(12):e51-e64. PubMed ID: 30566041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renovascular hypertension by two-kidney one-clip enhances endothelial progenitor cell mobilization in a p47phox-dependent manner.
    Salguero G; Akin E; Templin C; Kotlarz D; Doerries C; Landmesser U; Grote K; Schieffer B
    J Hypertens; 2008 Feb; 26(2):257-68. PubMed ID: 18192840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of a pulmonary origin for blood outgrowth endothelial cells by examination of identical twins harboring a BMPR2 mutation.
    Ormiston ML; Southgate L; Treacy C; Pepke-Zaba J; Trembath RC; Machado RD; Morrell NW
    Am J Respir Crit Care Med; 2013 Jul; 188(2):258-60. PubMed ID: 23855704
    [No Abstract]   [Full Text] [Related]  

  • 10. Do vasculature reactive oxygen species play a role in the mobilization of bone marrow endothelial progenitor cells?
    Kiyomoto H; Nishiyama A
    J Hypertens; 2008 Feb; 26(2):188-90. PubMed ID: 18192830
    [No Abstract]   [Full Text] [Related]  

  • 11. Endothelial progenitor cells in pulmonary arterial hypertension.
    Diller GP; Thum T; Wilkins MR; Wharton J
    Trends Cardiovasc Med; 2010 Jan; 20(1):22-9. PubMed ID: 20685574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of endothelial progenitor cells in pulmonary hypertension and diffuse lung diseases.
    Fadini GP; Schiavon M; Avogaro A; Agostini C
    Sarcoidosis Vasc Diffuse Lung Dis; 2007 Sep; 24(2):85-93. PubMed ID: 18496977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.
    Li M; Vattulainen S; Aho J; Orcholski M; Rojas V; Yuan K; Helenius M; Taimen P; Myllykangas S; De Jesus Perez V; Koskenvuo JW; Alastalo TP
    Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1118-28. PubMed ID: 24433082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin ameliorates hypoxia-induced pulmonary hypertension associated with down-regulated stromal cell-derived factor-1.
    Satoh K; Fukumoto Y; Nakano M; Sugimura K; Nawata J; Demachi J; Karibe A; Kagaya Y; Ishii N; Sugamura K; Shimokawa H
    Cardiovasc Res; 2009 Jan; 81(1):226-34. PubMed ID: 18779230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic, cellular and molecular mechanisms of pulmonary arterial hypertension].
    Alan B; Nalbantgil S
    Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():9-13. PubMed ID: 20819762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial progenitor cells: pathogenetic role and therapeutic perspectives.
    Allegra A; Coppolino G; Bolignano D; Giacobbe MS; Alonci A; D'Angelo A; Bellomo G; Teti D; Loddo S; Musolino C; Buemi M
    J Nephrol; 2009; 22(4):463-75. PubMed ID: 19662601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.
    Zhao YD; Courtman DW; Deng Y; Kugathasan L; Zhang Q; Stewart DJ
    Circ Res; 2005 Mar; 96(4):442-50. PubMed ID: 15692087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial-to-mesenchymal transition in pulmonary hypertension.
    Ranchoux B; Antigny F; Rucker-Martin C; Hautefort A; Péchoux C; Bogaard HJ; Dorfmüller P; Remy S; Lecerf F; Planté S; Chat S; Fadel E; Houssaini A; Anegon I; Adnot S; Simonneau G; Humbert M; Cohen-Kaminsky S; Perros F
    Circulation; 2015 Mar; 131(11):1006-18. PubMed ID: 25593290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
    Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
    Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice.
    Li L; Wei C; Kim IK; Janssen-Heininger Y; Gupta S
    Hypertension; 2014 Jun; 63(6):1260-9. PubMed ID: 24614212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.